 |
1-(2,8-Dimethyl-1-thia-3,8-diazaspiro[4.5]dec-3-yl)-3-(1H-indol-3-yl)propan-1-one |
|---|---|
| Trade Name | |
| Orphan Indication | Frontotemporal dementia |
| USA Market Approval | USA |
| USA Designation Date | 2016-04-06 00:00:00 |
| Sponsor | Anavex Life Sciences Corp.;51 West 52nd Street, 7th Floor;New York, New York, 10019 |
